Meeting
2014 ASCO Annual Meeting
Comparison of concurrent chemoradiation therapy with 3-weekly versus weekly cisplatin in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II noninferiority trial (KCSG-HN10-02).
Authors
Ji Yun Lee
Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Ji Yun Lee , Sung Hee Lim , Kwai Han Yoo , Moonjin Kim , Sungmin Kim , Hyun Ae Jung , Jong-Mu Sun , Sung-Bae Kim , Keon Uk Park , Hoon-Kyo Kim , Dae Sik Hong , Jun Suk Kim , Seong-Geun Kim , Seong Yoon Yi , Hwan Jung Yun , Myung Soo Hyun , Hyo Jung Kim , Keunchil Park , Yong Chan Ahn , Myung-Ju Ahn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 6023)
DOI
10.1200/jco.2014.32.15_suppl.6023
Abstract #
6023
Poster Bd #
39
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Safety and efficacy of docetaxel combined with cisplatin as induction chemotherapy followed by cisplatin concurrent chemoradiotherapy plus gemcitabine as adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A prospective and multicenter phase II trial.
First Author: Zhi Hui Wang
Poster
2013 ASCO Annual Meeting
Predictive values of (18)f-FDG PET standardized uptake value for adjuvant chemotherapy in patients with nasopharyngeal carcinoma.
First Author: Ching Chan Lin
Poster
2019 ASCO Annual Meeting
Impact of adjuvant chemotherapy and cumulative cisplatin dose in locally-advanced nasopharyngeal carcinoma (LA-NPC) treated with definitive chemoradiotherapy.
First Author: Marc Oliva Bernal
Poster
2013 ASCO Annual Meeting
Induction chemotherapy (CT) with docetaxel, cisplatin, and fluorouracil (TPF) followed by concomitant cisplatin plus radiotherapy in locally advanced nasopharyngeal cancer (NPC): Results after 06 years.
First Author: Esma Kerboua